SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-23-128667
Filing Date
2023-12-22
Accepted
2023-12-22 12:05:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2333378-1_sc13da.htm SC 13D/A 61969
  Complete submission text file 0001104659-23-128667.txt   63613
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Subject) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-42217 | Film No.: 231508259
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE BOW STREET CAMBRIDGE MA 02138
Business Address
Cherington Charles (Filed by) CIK: 0001448698 (see all company filings)

Type: SC 13D/A